文献速递前列腺癌

基于磁共振成像的T分期预测根治性前列腺切除术后生化复发:迈向iTNM分类的一步

Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.
PubMed 文献 · Eur Urol Oncol · 2022-10-21

这项回顾性多中心队列研究纳入2014至2021年间法国、意大利、瑞士和比利时八家转诊中心的1436例患者,比较基于直肠指检或mpMRI的四种T分期模型对根治性前列腺切除术后早期生化复发的预测能力。中位随访16个月后113例发生生化复发,基于mpMRI的新五分组T分类系统(模型4)在多变量分析中预测早期生化复发的预后区分度最高(C指数0.694),但各模型95%置信区间存在重叠。作者结论认为该mpMRI-based T分期需外部验证后方可应用于临床实践。

要点

  • 基于mpMRI的新五分组T分类系统预测早期生化复发的C指数为0.694,在各模型中最高。
  • 各T分期模型预测生化复发的95%置信区间存在重叠。
  • 作者结论认为该mpMRI-based T分期需外部验证后方可应用于临床实践。

核心结论

  • 作者描述了一种基于mpMRI的替代性T分期用于预测前列腺癌根治性切除术后早期生化复发,但结果需外部验证后方可应用于临床实践。

研究设计与样本

  • 回顾性多中心队列研究,2014年至2021年间在法国、意大利、瑞士和比利时的八家转诊中心共纳入1436例患者。
  • 生化复发定义为随访期间两次前列腺特异性抗原值≥0.2 ng/ml。
  • 采用Harrell一致性指数(C指数)比较四种基于直肠指检或mpMRI的T分期模型对生化复发的区分能力。

主要发现

  • 根据Mazzone风险分类,低危、中危、高危和极高危前列腺癌患者分别为74例(5%)、845例(59%)、482例(34%)和35例(2%)。
  • 中位随访16个月后,113例患者发生生化复发。
  • 多变量分析中,基于mpMRI的新五分组T分类系统(模型4)预测早期生化复发的预后区分度最高,C指数为0.694,但各模型95%置信区间存在重叠。
  • 敏感性分析排除cN1患者并与五分组直肠指检T分类(cT1c vs cT2a vs cT2b vs cT2c vs cT3)比较时,基于mpMRI的新T分期预测生化复发的C指数仍高于直肠指检,但模型间95%置信区间重叠仍然存在。

关键数值与推荐

  • 模型1基于直肠指检:cT1 vs cT2 vs cT3。
  • 模型2基于mpMRI:器官局限性疾病 vs 包膜外侵犯(iECE)vs 精囊侵犯(iSVI)。
  • 模型3基于mpMRI:PI-RADS ≤3 vs PI-RADS 4 vs PI-RADS 5。
  • 模型4基于mpMRI:iT2a(PI-RADS ≤3)vs iT2b(PI-RADS 4)vs iT2c(PI-RADS 5且无ECE或SVI)vs iT3a(ECE)vs iT3b(SVI)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 主要局限性是随访时间短。
  • 作者结论指出结果需外部验证后方可应用于临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Local staging of prostate cancer (PCa) still relies on digital rectal examination (DRE), which therefore remains the standard for risk stratification in guideline recommendations, clinical trials, and patient counseling. This issue is increasingly controversial as multiparametric magnetic resonance imaging (mpMRI) has become the most influential diagnostic tool for local staging of PCa over the past two decades. OBJECTIVE: To compare various models of T category based on DRE or mpMRI to predict early biochemical recurrence (BCR) after radical prostatectomy (RP). DESIGN, SETTING, AND PARTICIPANTS: A retrospective multicenter cohort study was conducted between 2014 and 2021. A total of 1436 patients were recruited across eight referral centers in France, Italy, Switzerland, and Belgium. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: BCR was defined as two prostate-specific antigen values of ≥0.2 ng/ml during follow-up. Harrell's concordance index (C index) was used to compare the discrimination of four models of T staging based on DRE (model 1: cT1 vs cT2 vs cT3) or mpMRI (model 2: organ-confined disease vs extracapsular extension [iECE] vs seminal vesicle invasion [iSVI]; model 3: Prostate Imaging-Reporting and Data System [PI-RADS] ≤3 vs PI-RADS 4 vs PI-RADS 5; and model 4: iT2a [PI-RADS ≤3] vs iT2b [PI-RADS 4] vs iT2c [PI-RADS 5 excluding ECE or SVI] vs iT3a [ECE] vs iT3b [SVI]) to predict BCR. RESULTS AND LIMITATIONS: Overall, 74 (5%), 845 (59%), 482 (34%), and 35 (2%) patients had low-, intermediate-, high-, and very high-risk PCa, respectively, according to the Mazzone risk classification. After median follow-up of 16 mo, 113 patients experienced BCR. Although the new five-group mpMRI-based T classification system (model 4) had the highest prognostic discrimination (C index 0.694) for predicting early BCR on multivariable analysis, there was overlap between the 95% confidence intervals of the models. On sensitivity analysis, the new mpMRI-based T staging still had a higher C index than DRE for predicting BCR when excluding cN1 patients and comparing it with a five-group DRE-based T classification (cT1c vs cT2a vs cT2b vs cT2c vs cT3), but the overlap between the 95% confidence intervals of the models remained. The main limitation is the short follow-up. CONCLUSIONS: We described an alternative mpMRI-based T staging for prediction of early BCR after RP for PCa. Our results need to be validated externally before they can be applied in clinical practice. PATIENT SUMMARY: At present, digital rectal examination of the prostate is used to stage prostate cancer. We developed an alternative model for staging that uses information from magnetic resonance imaging (MRI) scans to predict cancer outcomes for men undergoing surgical removal of the prostate.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Baboudjian M, Gondran-Tellier B, Touzani A, et al. Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification. Eur Urol Oncol. 2022. PMID: 36280445. doi:10.1016/j.euo.2022.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。